Clinical Trials Directory

Trials / Completed

CompletedNCT01200173

Effect of the Consumption of a Fermented Milk on Common Infections in Children Aged 3-6 Years, Attending Day Care Centers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
600 (actual)
Sponsor
Danone Global Research & Innovation Center · Industry
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Accepted

Summary

This multicentric, randomized, double-blind and controlled study aims to examine the effect of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel® = tested product) on the incidence of respiratory and gastro-intestinal common infectious diseases (cumulated number of infections during the intervention period: primary criteria) in children aged 3-6 years, attending day care centers.Volunteers received either 200g/day of tested product (N=300) or control product (N=299) for 3-months, followed by a 1-month follow-up.

Conditions

Interventions

TypeNameDescription
OTHER1-Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®)
OTHER2-Non fermented dairy product (control)

Timeline

Start date
2006-11-01
Primary completion
2007-04-01
Completion
2007-07-01
First posted
2010-09-13
Last updated
2016-11-25

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT01200173. Inclusion in this directory is not an endorsement.